Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Breast Cancer

Free Subscription Articles published in BMJ Retrieve available abstracts of 35 articles: HTML format

Single Articles

November 2023
1. WEAVER N
   We must remove access barriers to endocrine drugs for breast cancer prevention.
   BMJ. 2023;383:p2709.
   PubMed    
   
   
   
2. 
   Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
   BMJ. 2023;383:p2665.
   PubMed    
   
   
   
3. MAHASE E
   Anastrozole: Repurposed drug could prevent thousands of breast cancer cases.
   BMJ. 2023;383:p2608.
   PubMed    
   
   
   October 2023
4. MA F, Yan M, Li W, Ouyang Q, et al
   Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
   BMJ. 2023;383:e076065.
   PubMed     Abstract available
   
   
   
5. SCHMITZ RSJM, van den Belt-Dusebout AW, Clements K, Ren Y, et al
   Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
   BMJ. 2023;383:e076022.
   PubMed     Abstract available
   
   
   September 2023
6. DAVIES EA, Wang YH
   Understanding inequalities in breast cancer screening uptake.
   BMJ. 2023;382:p2084.
   PubMed    
   
   
   
7. HOFVIND S, Iqbal N, Thy JE, Mangerud G, et al
   Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway.
   BMJ. 2023;382:e075465.
   PubMed     Abstract available
   
   
   
8. CATHCART-RAKE EJ, Tevaarwerk AJ, Haddad TC, D'Andre SD, et al
   Advances in the care of breast cancer survivors.
   BMJ. 2023;382:e071565.
   PubMed     Abstract available
   
   
   
9. OKE JL, Welch HG
   Breast cancer: conflating case fatality with mortality.
   BMJ. 2023;382:p2086.
   PubMed    
   
   
   August 2023
10. MAHASE E
    Breast cancer screening: Overdiagnosis increases significantly with age, researchers say.
    BMJ. 2023;382:p1823.
    PubMed    
    
    
    July 2023
11. 
    Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study.
    BMJ. 2023;382:p1744.
    PubMed    
    
    
    June 2023
12. TAYLOR C, McGale P, Probert J, Broggio J, et al
    Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study.
    BMJ. 2023;381:e074684.
    PubMed     Abstract available
    
    
    
13. MACKENZIE M, Stobart H, Dodwell D, Taylor C, et al
    Risk of breast cancer death after a diagnosis of early invasive breast cancer.
    BMJ. 2023;381:p1355.
    PubMed    
    
    
    
14. KIRBY AM, Holt F, Taylor CW, Haviland JS, et al
    Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?
    BMJ. 2023;381:e072896.
    PubMed    
    
    
    May 2023
15. LEON-FERRE RA, Goetz MP
    Advances in systemic therapies for triple negative breast cancer.
    BMJ. 2023;381:e071674.
    PubMed     Abstract available
    
    
    
16. TANNE JH
    Breast cancer: US recommends women start screening at 40.
    BMJ. 2023;381:1077.
    PubMed    
    
    
    
17. CLIFT AK, Dodwell D, Lord S, Petrou S, et al
    Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
    BMJ. 2023;381:e073800.
    PubMed     Abstract available
    
    
    April 2023
18. GATHANI T, Cutress R, Horgan K, Kirwan C, et al
    Age and sex can predict cancer risk in people referred with breast symptoms.
    BMJ. 2023;381:e073269.
    PubMed    
    
    
    March 2023
19. FLEMING B, Edison P, Kenny L
    Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management.
    BMJ. 2023;380:e071726.
    PubMed     Abstract available
    
    
    February 2023
20. BERDZULI N
    Breast cancer: from awareness to access.
    BMJ. 2023;380:290.
    PubMed    
    
    
    January 2023
21. LIMB M
    Black women in England are at greater risk of late cancer diagnosis than white women.
    BMJ. 2023;380:211.
    PubMed    
    
    
    September 2022
22. BUNDRED JR, Michael S, Stuart B, Cutress RI, et al
    Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis.
    BMJ. 2022;378:e070346.
    PubMed     Abstract available
    
    
    
23. BUNDRED NJ, Bundred JR, Cutress RI, Dodwell D, et al
    Width of excision margins after breast conserving surgery for invasive breast cancer and distant recurrence and survival.
    BMJ. 2022;378:o2077.
    PubMed    
    
    
    July 2022
24. MENKES DB, Hoeh NR
    Doctor-patient relationship is essential to curtail overdiagnosis.
    BMJ. 2022;378:o1750.
    PubMed    
    
    
    
25. WISE J
    NICE approves two more treatment options for advanced breast cancer.
    BMJ. 2022;378:o1751.
    PubMed    
    
    
    June 2022
26. IACOBUCCI G
    NICE recommends new targeted treatment for early breast cancer.
    BMJ. 2022;377:o1491.
    PubMed    
    
    
    
27. PAPAUTSKY EL
    A full time job: a year with early-stage breast cancer.
    BMJ. 2022;377:o1421.
    PubMed    
    
    
    May 2022
28. WISE J
    NICE allows immunotherapy treatment for small group of patients with advanced triple negative breast cancer.
    BMJ. 2022;377:o1311.
    PubMed    
    
    
    
29. WISE J
    Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes.
    BMJ. 2022;377:o1226.
    PubMed    
    
    
    March 2022
30. SAUL H, Gursul D, Cassidy S, Vinogradova Y, et al
    Risk of breast cancer with HRT depends on therapy type and duration.
    BMJ. 2022;376:o485.
    PubMed     Abstract available
    
    
    
31. TANNE JH
    Breast cancer is overdiagnosed in one in six or seven cases, finds large US study.
    BMJ. 2022;376:o581.
    PubMed    
    
    
    January 2022
32. BARTHOLOMEW T, Colleoni M, Schmidt H
    Financial incentives for breast cancer screening undermine informed choice.
    BMJ. 2022;376:e065726.
    PubMed    
    
    
    December 2021
33. CONFORTI F, Pala L, Sala I, Oriecuia C, et al
    Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis.
    BMJ. 2021;375:e066381.
    PubMed     Abstract available
    
    
    
34. KRZYZANOWSKA MK, Julian JA, Gu CS, Powis M, et al
    Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
    BMJ. 2021;375:e066588.
    PubMed     Abstract available
    
    
    November 2021
35. BRUCE J, Mazuquin B, Canaway A, Hossain A, et al
    Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.
    BMJ. 2021;375:e066542.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.